LEFT ATRIAL APPENDAGE CLOSURE
Clinical trials for LEFT ATRIAL APPENDAGE CLOSURE explained in plain language.
Never miss a new study
Get alerted when new LEFT ATRIAL APPENDAGE CLOSURE trials appear
Sign up with your email to follow new studies for LEFT ATRIAL APPENDAGE CLOSURE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New heart device aims to make key procedure safer and easier
Disease control Recruiting nowThis early study tests a new tool called the Agilis RF Transseptal System, which uses radiofrequency energy to safely cross the wall between the upper chambers of the heart. The goal is to help doctors access the left side of the heart during treatments for heart rhythm issues or…
Matched conditions: LEFT ATRIAL APPENDAGE CLOSURE
Phase: NA • Sponsor: Abbott Medical Devices • Aim: Disease control
Last updated May 17, 2026 05:35 UTC
-
New heart imaging technique could make stroke prevention safer and easier
Disease control Recruiting nowThis study compares two ways to guide a procedure that closes off a part of the heart to prevent strokes in people with atrial fibrillation. The standard method uses a probe down the throat (TEE), while the new method uses a probe inside the heart (ICE). The goal is to see if the…
Matched conditions: LEFT ATRIAL APPENDAGE CLOSURE
Phase: NA • Sponsor: Baylor Research Institute • Aim: Disease control
Last updated May 17, 2026 05:34 UTC
-
New registry tracks safety of Stroke-Prevention device in AF patients
Disease control Recruiting nowThis study is collecting real-world data on the WATCHMAN FLX Pro device, which is used to close off a part of the heart called the left atrial appendage in people with non-valvular atrial fibrillation. The goal is to reduce stroke risk without needing lifelong blood thinners. Abo…
Matched conditions: LEFT ATRIAL APPENDAGE CLOSURE
Phase: NA • Sponsor: Boston Scientific Corporation • Aim: Disease control
Last updated May 17, 2026 05:34 UTC
-
Heart study aims to cut bleeding risk with shorter blood thinner use
Disease control Recruiting nowThis study looks at whether people with atrial fibrillation can safely take a lower dose of the blood thinner apixaban for just 3 months after a procedure to close a part of the heart (left atrial appendage), then stop all blood thinners. The goal is to see if this approach reduc…
Matched conditions: LEFT ATRIAL APPENDAGE CLOSURE
Sponsor: National Medical Research Center for Therapy and Preventive Medicine • Aim: Disease control
Last updated May 14, 2026 12:06 UTC